Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2021-04-09
Original market date: See footnote 1
Product name:
FLURAZEPAM 15MG CAPSULE
DIN:
02232656 Electronic product monograph is not available
Company:
LABORATOIRES CONFAB INC
4355 Boul. Sir Wilfrid Laurier
St-Hubert
Quebec
Canada
J3Y 3X3
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Targeted (CDSA IV)
American Hospital Formulary Service (AHFS): See footnote 3
28:24.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05CD01 FLURAZEPAM
Active ingredient group (AIG) number:See footnote5
0108704002
Active ingredient(s) See footnote8 | Strength |
---|---|
FLURAZEPAM HYDROCHLORIDE | 15 MG / CAP |